In last trading session, IGC Pharma Inc (AMEX:IGC) saw 1.13 million shares changing hands with its beta currently measuring 1.39. Company’s recent per share price level of $0.34 trading at $0.03 or 9.59% at ring of the bell on the day assigns it a market valuation of $27.31M. That closing price of IGC’s stock is at a discount of -167.65% from its 52-week high price of $0.91 and is indicating a premium of 23.53% from its 52-week low price of $0.26. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.5 million shares which gives us an average trading volume of 397.87K if we extend that period to 3-months.
For IGC Pharma Inc (IGC), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.00. Splitting up the data highlights that, out of 1 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 1 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -0.02 in the current quarter.
IGC Pharma Inc (AMEX:IGC) trade information
Upright in the green during last session for gaining 9.59%, in the last five days IGC remained trading in the green while hitting it’s week-highest on Wednesday, 03/12/25 when the stock touched $0.34 price level, adding 4.23% to its value on the day. IGC Pharma Inc’s shares saw a change of 1.99% in year-to-date performance and have moved 22.35% in past 5-day. IGC Pharma Inc (AMEX:IGC) showed a performance of 11.23% in past 30-days. Number of shares sold short was 0.94 million shares which calculate 2.53 days to cover the short interests.
IGC Pharma Inc (IGC) estimates and forecasts
This year revenue growth is estimated to fall -7.36% from the last financial year’s standing.
2 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of 305k for the same. And 1 analysts are in estimates of company making revenue of 326k in the next quarter. Company posted 295k and 272k of sales in current and next quarters respectively a year earlier.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -13.79% during past 5 years. In 2025, company’s earnings growth rate is likely to be around 54.55% while estimates for its earnings growth in next 5 years are of 18.29%.
IGC Pharma Inc (AMEX:IGC)’s Major holders
Insiders are in possession of 7.52% of company’s total shares while institution are holding 20.91 percent of that, with stock having share float percentage of 22.61%. Investors also watch the number of corporate investors in a company very closely, which is 20.91% institutions for IGC Pharma Inc that are currently holding shares of the company. BLACKROCK INC. is the top institutional holder at IGC for having 0.7 million shares of worth $0.31 million. And as of 2024-06-30, it was holding 1.1961 of the company’s outstanding shares.
The second largest institutional holder is VANGUARD GROUP INC, which was holding about 0.65 million shares on 2024-06-30. The number of shares represents firm’s hold over 1.0965 of outstanding shares, having a total worth of $0.28 million.
